financetom
Business
financetom
/
Business
/
Bentley looks to launches after 'emotional sensitivity' slowed car sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bentley looks to launches after 'emotional sensitivity' slowed car sales
Mar 19, 2024 3:05 AM

LONDON (Reuters) - British luxury carmaker Bentley on Tuesday reported a lower operating profit for 2023 after a weak economy and high interest rates hit sales, but the company said its performance had stabilised and new launches would boost it in 2024.

"We had an uneven performance for the first time in about four years," CEO Adrian Hallmark told reporters. "Even though our customers can still afford our cars... there was a level of emotional sensitivity that slowed down demand."

For those who leased rather than bought cars with a starting pre-tax price above 220,000 euros ($238,590), interest rates had led to a tripling in monthly fees last year, Hallmark said.

He said the launch of four high-performance hybrids this year should spur sales as the company gears up to launch its first fully electric Bentley in 2026.

Bentley is aiming for an all-electric model lineup by 2030, but Hallmark said its hybrids were likely to be on sale after that deadline as the company seeks to ensure a return on its substantial investment.

The luxury automaker in January reported an 11% drop in sales for 2023 following a record year in 2022.

The British luxury unit of Volkswagen posted an operating profit of 589 million pounds ($748 million) for 2023, down nearly 17% from 708 million pounds in 2022.

Revenue was down 13% at 2.94 billion pounds from a year earlier and the company said its profit margin dropped to 20.1% from 20.9% in 2022 because of investments in new vehicles.

($1 = 0.7872 pounds)

($1 = 0.9221 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vecima Networks Announces First U.S.-made Electronics Equipment
Vecima Networks Announces First U.S.-made Electronics Equipment
Aug 20, 2024
08:00 AM EDT, 08/20/2024 (MT Newswires) -- Vecima Networks ( VNWTF ) on Tuesday said its first U.S.-made internet network electronics equipment will roll off the production line next week at MARA Technologies USA's Holly, Michigan manufacturing facility. The production is part of the Build America Buy America (BABA) requirements for the Broadband Equity Access and Deployment (BEAD) Program, the...
Blue Sky Uranium Notes Positive Tax Measures in Argentina as Work Continues at Amarillo Grande Project
Blue Sky Uranium Notes Positive Tax Measures in Argentina as Work Continues at Amarillo Grande Project
Aug 20, 2024
07:54 AM EDT, 08/20/2024 (MT Newswires) -- Blue Sky Uranium ( BKUCF ) said Tuesday that it expects its Amarillo Grande project in Argentina's Rio Negro province to benefit from the country's new positive tax measures. Blue Sky said the province was the first Argentine province to adopt the Incentive Regime for Large Investments under the Bases Law, which grants...
Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment
Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment
Aug 20, 2024
07:58 AM EDT, 08/20/2024 (MT Newswires) -- Tonix Pharmaceuticals ( TNXP ) said Tuesday its first patient was dosed in its phase 2, single-blind, placebo-controlled trial of TNX-1300 for treating acute cocaine intoxication in emergency departments. TNX-1300 is a recombinant enzyme that degrades and metabolizes cocaine in cocaine users. The trial will assess the safety and efficacy of a single...
Exact Sciences's Multi-Cancer Early Detection Study Enrols First Patient
Exact Sciences's Multi-Cancer Early Detection Study Enrols First Patient
Aug 20, 2024
07:44 AM EDT, 08/20/2024 (MT Newswires) -- Exact Sciences ( EXAS ) said on Tuesday the first patient had joined its multi-cancer early detection falcon registry study at Baylor Scott & White, its primary study site in Texas. The company said the study, involving up to 25,000 patients, would assess the performance, experience, and impact of multi-cancer early detection testing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved